TriSalus Life Sciences, Inc.
TLSIW- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001826667
No open-market purchases or sales by TriSalus Life Sciences, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $798.0K in total; no superinvestor holds it.
Other share classesTLSI
13F holders, Q3 2024
Institutional positions in TriSalus Life Sciences, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −11 vs. Q2 2024
- Shares held
- 191.8K
- −1.97M (−91.1%) vs. Q2 2024
- Total value
- $208.0K
- −$3.50M (−94.4%) vs. Q2 2024
- New holders
- 2
- 1 more added
- Sold out
- 13
- 2 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLSIW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $798.0K |
| Q1 2026 | 7 | $1.23M |
| Q4 2025 | 8 | $1.77M |
| Q3 2025 | 4 | $337.4K |
| Q2 2025 | 5 | $1.25M |
| Q1 2025 | 6 | $1.11M |
| Q4 2024 | 8 | $1.08M |
| Q3 2024 | 8 | $208.0K |
| Q2 2024 | 19 | $3.71M |
| Q1 2024 | 22 | $3.33M |
| Q4 2023 | 23 | $3.72M |
| Q3 2023 | 20 | $1.20M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding TriSalus Life Sciences, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vestcor Inc | 70,832 | $74.0K | 0.00% | −77,923−52.4% | Reduced |
| Foster Victor Wealth Advisors, LLC | 22,158 | $33.2K | 0.00% | +1,000+4.7% | Added |
| HRT Financial LP | 28,250 | $29.0K | 0.00% | −1,681−5.6% | Reduced |
| B & T Capital Management DBA Alpha Capital Management | 22,222 | $22.4K | 0.00% | 00.0% | Unchanged |
| Cowen and Company, LLC | 20,369 | $20.6K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 14,751 | $14.9K | 0.00% | +14,751 | New |
| GTS Securities LLC | 13,132 | $13.8K | 0.00% | +13,132 | New |
| Tower Research Capital LLC (TRC) | 42 | $42 | 0.00% | 00.0% | Unchanged |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −642,163−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −333,333−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −259,262−100.0% | Sold out |
| MSD Partners, L.P. | 0 | $0 | 0.00% | −133,333−100.0% | Sold out |
| Bluefin Capital Management, LLC | 0 | $0 | 0.00% | −115,989−100.0% | Sold out |
| Bracebridge Capital, LLC | 0 | $0 | 0.00% | −92,880−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −80,883−100.0% | Sold out |
| Cable Car Capital LLC | 0 | $0 | 0.00% | −76,287−100.0% | Sold out |
| Sequoia Financial Advisors, LLC | 0 | $0 | 0.00% | −62,187−100.0% | Sold out |
| CastleKnight Management LP | 0 | $0 | 0.00% | −46,371−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −45,496−100.0% | Sold out |
| Kim, LLC | 0 | $0 | 0.00% | −19,007−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |